Scarica l'app Stockscreener
19.33
3.37%
0.63
Precedente Chiudi:
$18.70
Aprire:
$18.3692
Volume 24 ore:
2.47M
Relative Volume:
0.81
Capitalizzazione di mercato:
$4.61B
Reddito:
$426.45M
Utile/perdita netta:
$197.67M
Rapporto P/E:
23.57
EPS:
0.82
Flusso di cassa netto:
$110.10M
1 W Prestazione:
+7.33%
1M Prestazione:
+8.11%
6M Prestazione:
+19.69%
1 anno Prestazione:
+57.73%
Intervallo 1D:
$18.22
$19.44
Intervallo di 1 settimana:
$18.00
$19.44
Portata 52W:
$10.21
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
19.33 | 4.46B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Is ADMA Biologics Inc. stock overvalued or undervaluedOutstanding yields - jammulinksnews.com
Is it the right time to buy ADMA Biologics Inc. stockBuild a diversified portfolio for steady growth - jammulinksnews.com
What institutional investors are buying ADMA Biologics Inc. stockMaximize gains with timely market signals - jammulinksnews.com
What analysts say about ADMA Biologics Inc. stockInvest in high-yield stocks with confidence - jammulinksnews.com
ADMA Biologics Inc. warns investors of significant business risks in latest report. - AInvest
Is ADMA Biologics Inc. a good long term investmentMaximize profits with strategic stock selection - jammulinksnews.com
What drives ADMA Biologics Inc. stock priceUnlock your trading potential with expert tips - jammulinksnews.com
ADMA Biologics Inc. Warns Investors of Significant Business Risks in Latest Report - The Globe and Mail
Is ADMA Biologics Inc. Forming a Consolidation BaseWatchlist for Smart Swing Trading Updated - metal.it
ADMA Biologics Inc. May Be Forming Higher Low — Chartwatchers AlertSmart Trade Plans With Risk Protection Explained - metal.it
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewswire
ADMA Biologics to Report Second Quarter 2025 Financial Results o - GuruFocus
ADMA Biologics Earnings: Biopharma Leader Sets Q2 2025 Financial Results Release for August 6 - Stock Titan
Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
How did ADMA's revenue surge in Q4 2024 impact its profitability? - AInvest
How ADMA Biologics Inc. stock performs during market volatilityRisk Controlled Picks With Real Returns Outlined - metal.it
ADMA Biologics Inc. Recovers — But Is It SustainableEntry Alert Based on Volume Spikes Detected - metal.it
ADMA Biologics Inc. Approaches Support With Recovery in SightMomentum Based Equity Trading Plans Reviewed - metal.it
Is ADMA Biologics Inc. a growth stock or a value stockGet timely alerts on market opportunities - jammulinksnews.com
How strong is ADMA Biologics Inc. company’s balance sheetMaximize gains with strategic stock entries - jammulinksnews.com
High Growth Tech Stocks In The US To Watch This July 2025 - Yahoo Finance
When is ADMA Biologics Inc. stock expected to show significant growthCapitalize on momentum-driven opportunities - jammulinksnews.com
What are ADMA Biologics Inc. company’s key revenue driversMarket-crushing profits - jammulinksnews.com
How does ADMA Biologics Inc. compare to its industry peersHigh-velocity gains - jammulinksnews.com
What are analysts’ price targets for ADMA Biologics Inc. in the next 12 monthsSuperior trading gains - jammulinksnews.com
Does ADMA Biologics Inc. stock perform well during market downturnsAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Heavy Insider Selling at ADMA Biologics Despite Earnings Strength - MSN
What risks could impact ADMA Biologics Inc. stock performanceStrong return on assets - jammulinksnews.com
When is the best time to buy ADMA Biologics Inc. stockOutstanding capital returns - jammulinksnews.com
Investing in ADMA Biologics (NASDAQ:ADMA) three years ago would have delivered you a 696% gain - Yahoo Finance
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - Yahoo Finance
ADMA Biologics Inc. Stock Analysis and ForecastMassive portfolio appreciation - jammulinksnews.com
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):